The effect of bronchobarij on treatment of cough

The effect of Bronchobarij Syrup on severity of cough and its comparison with Dextromethorphan in patient with persecutor and idiopathic cough

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014022512438N5

Enrollment

200

Registered

2014-04-02

Start date

2014-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cough. Cough

Interventions

Intervention 1: Intervention: bronchobarij syrup- TDS,5cc for 4 days. Intervention 2: Control: dextromethorphan syrup-TDS, 5cc for 4 days.

Treatment - Drugs

Intervention: bronchobarij syrup- TDS,5cc for 4 days

Control: dextromethorphan syrup-TDS, 5cc for 4 days

Eligibility

Sex/Gender

All

Age

10 Years to 149 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:persecutor and idiopathic cough,cough duration10 old. exclusion criteria :presence of allergies or contraindications taking dextromethorphan or bronchobarij,need special treatment or a particularly aggressive during the study period, a chronic condition that requires long-term treatment of Pharmacology in this time,participation in other trials during the past 15 days.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of cough. Timepoint: daily- 4 days. Method of measurement: Visual Analogue Scale (VAS).	—

Secondary

Measure	Time frame
Amelioration in cough. Timepoint: daily- 4days. Method of measurement: complete-partial-none(questionnaire).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.M.Taghizadeh

Kashan University of Medical Sciences

taghizadeh_m@kaums.ac.ir+98 36 1555 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026